| |
 |
|
Class Information
Number: 514/183
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai
Description: Subject matter which includes a compound containing a ring composed of carbon and at least one element from the group consisting of nitrogen, sulfur, selenium, tellurium and oxygen as DOAI.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/184 |
Heavy metal containing (including salts) |
555 |
| 514/191 |
Aluminum (including salts) |
54 |
| 514/192 |
1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.) |
269 |
| 514/200 |
1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.) |
180 |
| 514/210.01 |
Hetero ring is four-membered and includes at least one ring nitrogen |
166 |
| 514/211.01 |
Hetero ring contains seven members including nitrogen, carbon and chalcogen |
168 |
| 514/212.01 |
Hetero ring is seven-membered consisting of one nitrogen and six carbons |
229 |
| 514/218 |
Hetero ring is seven-membered consisting of two nitrogens and five carbon atoms |
854 |
| 514/222.2 |
Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members |
166 |
| 514/228.8 |
Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) |
266 |
| 514/241 |
Hetero ring is six-membered consisting of three nitrogens and three carbon atoms |
587 |
| 514/247 |
Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) |
743 |
| 514/277 |
Hetero ring is six-membered consisting of one nitrogen and five carbon atoms |
866 |
| 514/359 |
Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) |
597 |
| 514/430 |
Sulfur containing hetero ring |
107 |
| 514/449 |
Oxygen containing hetero ring |
562 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6492372 |
Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
Dec. 10, 2002 |
| 6489314 |
Epothilone derivatives and methods for making and using the same |
Dec. 3, 2002 |
| 6489340 |
Macrolide compounds for inducing chondrogenic differentiation |
Dec. 3, 2002 |
| 6482845 |
Method for inhibiting interleukin-2 production using tricyclo compounds |
Nov. 19, 2002 |
| 6479477 |
Substituted porphyrins |
Nov. 12, 2002 |
| 6476016 |
Cyclic oxyguanidine pyrazinones as protease inhibitors |
Nov. 5, 2002 |
| 6476054 |
Cyclic amine modulators of chemokine receptor activity |
Nov. 5, 2002 |
| 6472158 |
Ustilipides, method for the production and the use thereof |
Oct. 29, 2002 |
| 6465448 |
Methoxyamine potentiation of temozolomide anti-cancer activity |
Oct. 15, 2002 |
| 6465449 |
Heteroaromatic bicyclic derivatives useful as anticancer agents |
Oct. 15, 2002 |
| 6465491 |
6-phenylpyridyl-2-amine derivatives |
Oct. 15, 2002 |
| 6462024 |
Use of inhibitors of the sodium-hydrogen exchanger for the production of a medicament for decreasing undesired effects of substrates of the heart |
Oct. 8, 2002 |
| 6462034 |
Local anesthetic compounds and uses |
Oct. 8, 2002 |
| 6462035 |
Aryl fused azapolycyclic compounds |
Oct. 8, 2002 |
| 6455518 |
Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-O-(2-hydroxyethyl)-rapamycin |
Sep. 24, 2002 |
| 6455519 |
Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity |
Sep. 24, 2002 |
| 6455573 |
Glycosidase inhibitors and methods of synthesizing same |
Sep. 24, 2002 |
| 6451772 |
Biopolymer salts with low endotoxin levels, biopolymer compositions thereof and methods of making the same |
Sep. 17, 2002 |
| 6451783 |
Treatments for obesity and methods for identifying compounds useful for treating obesity |
Sep. 17, 2002 |
| 6451848 |
Compositions and methods comprising morphine gluconate |
Sep. 17, 2002 |
| 6448241 |
Thiazolobenzoheterocycles, their preparation and medicaments containing them |
Sep. 10, 2002 |
| 6444194 |
Indium photosensitizers for PDT |
Sep. 3, 2002 |
| 6444230 |
Synergistic composition of peracetic acid and amine oxide |
Sep. 3, 2002 |
| 6444233 |
Triterpene compositions and methods for use thereof |
Sep. 3, 2002 |
| 6444638 |
Combinations of PKC inhibitors and therapeutic agents for treating cancers |
Sep. 3, 2002 |
| 6444648 |
Leishmaniasis remedy containing glucopyranose derivative as the active ingredient |
Sep. 3, 2002 |
| 6440955 |
Reverse-turn mimetics and methods relating thereto |
Aug. 27, 2002 |
| 6441053 |
Inhibitors of glycogen synthase kinase-3 and methods for identifying and using the same |
Aug. 27, 2002 |
| 6429209 |
Methods for treating irritable bowel syndrome |
Aug. 6, 2002 |
| 6423722 |
Crystalline macrolides and process for their preparation |
Jul. 23, 2002 |
| 6420354 |
Sodium channel drugs and uses |
Jul. 16, 2002 |
| 6420395 |
Azacyclooctane and heptane derivatives, their preparation and use in therapy |
Jul. 16, 2002 |
| 6416752 |
Termite bait composition and method |
Jul. 9, 2002 |
| 6417180 |
Zinc finger-reactive antimicrobial compounds |
Jul. 9, 2002 |
| 6417181 |
Naphthyl-substituted and anilide-substituted sulfonamides |
Jul. 9, 2002 |
| 6407083 |
Uses of novel organoselenium compounds with pro-oxidant activity |
Jun. 18, 2002 |
| 6407087 |
UCF116 derivatives |
Jun. 18, 2002 |
| 6407088 |
Method of analgesia |
Jun. 18, 2002 |
| 6407089 |
Triazatrinaphthyrins and the use thereof |
Jun. 18, 2002 |
| 6403584 |
Substituted nipecotyl derivatives as inhibitors of cell adhesion |
Jun. 11, 2002 |
| 6399596 |
Avermectin pesticide with an organosilicone surfactant |
Jun. 4, 2002 |
| 6399613 |
Pyrazine derivatives, their preparation and medicaments containing them |
Jun. 4, 2002 |
| 6399620 |
Cycloalkyl derivatives as inhibitors of bone resporption and vitronectin receptor antagonists |
Jun. 4, 2002 |
| 6395724 |
Multibinding inhibitors of cyclooxygenase-2 |
May. 28, 2002 |
| 6395725 |
Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals |
May. 28, 2002 |
| 6387891 |
COMPOUNDS WITH CHELATION AFFINITY AND SELECTIVITY FOR FIRST TRANSITION SERIES ELEMENTS AND THEIR USE IN COSMETICS AND PERSONAL CARE PRODUCTS, INHIBITION OF METALLOENZYMES, AND INHIBITION OF RE |
May. 14, 2002 |
| 6384026 |
Macrocyclic polyamine lactones and derivatives thereof and their use as arthropod repellents |
May. 7, 2002 |
| 6384027 |
Phthalocyanine analogs |
May. 7, 2002 |
| 6380180 |
Potassium channel blocking agents |
Apr. 30, 2002 |
| 6372239 |
Compositions and methods for controlling pests using synergistic cocktails of plant alkaloids |
Apr. 16, 2002 |
|
|
|
